Public Health Effects of Medical Marijuana Legalization in Colorado

American Journal of Preventive Medicine

Volumn 50, Issue 3, 2016, Pages 373-379

  Davis, Jonathan M ^a   Mendelson, Bruce ^b   Berkes, Jay J ^a   Suleta, Katie ^a   Corsi, Karen F ^a   Booth, Robert E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Denver Office of Drug Strategy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; DRUG LEGISLATION; HOSPITAL DISCHARGE; HUMAN; OBSERVATIONAL STUDY; POISON CENTER; PUBLIC HEALTH; TIME SERIES ANALYSIS; UNITED STATES; CANNABIS SMOKING; COLORADO; EPIDEMIOLOGY; HOTLINE; LEGISLATION AND JURISPRUDENCE; MARIJUANA ABUSE; REGISTER; REGRESSION ANALYSIS; TRENDS;

COLORADO; HOTLINES; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; LEGISLATION, DRUG; MARIJUANA ABUSE; MARIJUANA SMOKING; MEDICAL MARIJUANA; PATIENT DISCHARGE; PUBLIC HEALTH; REGISTRIES; REGRESSION ANALYSIS;

EID: 84958166936     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2015.06.034     Document Type: Article

References (24)

1. Colorado Constitution. 0-4-287, Article XVIII, Miscellaneous Art. XVIII, Miscellaneous. November 2000. www.colorado.gov/pacific/sites/default/files/CHEIS-MMJ-Colorado-Constitution-Article-XVIII.pdf.
2. J. Schuermeyer, S. Salomonsen-Sautel, R.K. Price, and et al. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11 Dru Alcohol Depend 140 2014 145 155 10.1016/j.drugalcdep.2014.04.016
3. Ogden D. Memorandum for Selected United State Attorneys: Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana. U.S. Department of Justice, Office of the Deputy Attorney General; 2009. http://blogs.justice.gov/main/archives/192. Accessed June 16, 2014.
4. The Legalization of Marijuana in Colorado Rocky Mt High Intensity Drug Traffick Area 1 2013 1 58
5. J.R. Kilmer, S.B. Hunt, C.M. Lee, and C. Neighbors Marijuana use, risk perception, and consequences: is perceived risk congruent with reality? Addict Behav 32 12 2007 3026 3033 10.1016/j.addbeh.2007.07.009
6. L. Johnston, P. O'Malley, J. Bachman, J. Schulenberg, and R.A. Miech Monitoring the Future National Survey Results on Drug Use, 1975-2013: Volume I, Secondary School Students 2014 Institute for Social Research, the University of Michigan Ann Arbor, MI
7. B. Friese, and J.W. Grube Legalization of medical marijuana and marijuana use among youths Drugs Abingdon Engl 20 1 2013 33 39 10.3109/09687637.2012.713408
8. Medical Marijuana Statistics: Medical Marijuana Registry Applicants 2009-2014. https://www.colorado.gov/pacific/cdphe/statistics-and-data. Published 2014.
9. R.C. Dart Monitoring risk: post marketing surveillance and signal detection Drug Alcohol Depend 105 suppl 1 2009 S26 S32 10.1016/j.drugalcdep.2009.08.011
10. J.M. Davis, V.B. Searles, S.G. Severtson, R.C. Dart, and B. Bucher-Bartelson Seasonal variation in suicidal behavior with prescription opioid medication J Affect Disord 158 2014 30 36 10.1016/j.jad.2014.01.010
11. M.-C. Le Lait, E.M. Martinez, S.G. Severtson, S.A. Lavery, B. Bucher-Bartelson, and R.C. Dart Assessment of prescription opioid intentional exposures across the rural-urban continuum in the United States using both population and drug availability rates Pharmacoepidemiol Drug Saf 23 12 2014 1334 1337 10.1002/pds.3653
12. S.G. Severtson, B.B. Bartelson, J.M. Davis, and et al. Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010 J Pain Off J Am Pain Soc 14 10 2013 1122 1130 10.1016/j.jpain.2013.04.011
13. S. Salomonsen-Sautel, S.-J. Min, J.T. Sakai, and et al. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado Drug Alcohol Depend 140 2014 137 144 10.1016/j.drugalcdep.2014.04.008
14. J.M. Davis, S.G. Severtson, B. Bucher-Bartelson, and R.C. Dart Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits Pharmacoepidemiol Drug Saf 23 1 2014 18 25 10.1002/pds.3533
15. N. Dasgupta, J. Davis, M. Jonsson Funk, and R. Dart Using poison center exposure calls to predict methadone poisoning deaths PLoS One 7 7 2012 e41181 10.1371/journal.pone.0041181
16. R.J. MacCoun, and M.M. Mello Half-baked - the retail promotion of marijuana edibles N Engl J Med 372 11 2015 989 991 10.1056/NEJMp1416014
17. Drug Abuse Warning Network, 2009 National estimates of drug-related emergency department visits Subst Abuse Ment Health Serv Adm 2012 HHS Publication No. (SMA) 12-4733
18. B.C. Kelly, B.E. Wells, M. Pawson, A. LeClair, and J.T. Parsons Combinations of prescription drug misuse and illicit drugs among young adults Addict Behav 39 5 2014 941 944 10.1016/j.addbeh.2013.12.003
19. S.E. McCabe, C.J. Boyd, and C.J. Teter Medical use, illicit use, and diversion of abusable prescription drugs J Am Coll Health J ACH 54 5 2006 269 278 10.3200/JACH.54.5.269-278
20. M. Earleywine, and M.D. Newcomb Concurrent versus simultaneous polydrug use: prevalence, correlates, discriminant validity, and prospective effects on health outcomes Exp Clin Psychopharmacol 5 4 1997 353 364 10.1037/1064-1297.5.4.353
21. C.S. Martin, P.R. Clifford, and R.L. Clapper Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students J Subst Abuse 4 3 1992 319 326 10.1016/0899-3289(92)90039-Z
22. K.B. Kaloyanides, S.E. McCabe, J.A. Cranford, and C.J. Teter Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants Pharmacotherapy 27 5 2007 666 674 10.1592/phco.27.5.666
23. L.-H. Quek, G.C.K. Chan, A. White, and et al. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults Front Public Health 1 2013 61 10.3389/fpubh.2013.00061
24. J.F. Kelly, J.W. Finney, and R. Moos Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes J Subst Abuse Treat 28 3 2005 213 223 10.1016/j.jsat.2004.10.014